InsiderClue
← All stocks

Arcutis Biotherapeutics, Inc.

ARQT Mostly scheduled
CIK 0001787306 #1713 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$17.16M
$10.54M on a plan · $5.84M straight out of an exercise
Sold at will
$778.75K
2 of 82 sales
Net
−$17.16M
−$778.75K against sales at will

By person

16 insiders · 82 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Watanabe Todd
See Remarks
—
$5.32M (13) scheduled
−$5.32M
742,613
0.5908%
$18.58M
−8.3%
Welgus Howard G.
Director
—
$2.31M (13) scheduled
−$2.31M
36,475
0.0290%
$912.83K
−81.0%
Matsuda Masaru
See Remarks
—
$2.12M (17) scheduled
−$2.12M
116,182
0.0924%
$2.91M
−38.8%
Burnett Patrick
See Remarks
—
$2.02M (18) scheduled
−$2.02M
117,592
0.0936%
$2.94M
−44.4%
Leonard Keith R
Director
—
$997.19K (1) scheduled
−$997.19K
27,901
0.0222%
$698.25K
+48.2%
Curran Terrie
Director
—
$984.04K (3) scheduled
−$984.04K
23,526
0.0187%
$588.76K
+25.0%
Edwards Larry Todd
See Remarks
—
$968.36K (6)
−$968.36K
175,178
0.1394%
$4.38M
+23.5%
Krishnamohan Neha
Director
—
$939.49K (2) scheduled
−$939.49K
27,901
0.0222%
$698.25K
+77.2%
LIN SUE-JEAN
Director
—
$898.54K (2) scheduled
−$898.54K
27,567
0.0219%
$689.89K
+44.1%
Gilbert Halley E
Director
—
$455.44K (1) scheduled
−$455.44K
27,901
0.0222%
$698.25K
+48.2%
Vairavan Latha
SVP Chief Financial Officer
—
$148.50K (6) scheduled
−$148.50K
85,978
0.0684%
$2.15M
+90.6%
CHAUDHURI BHASKAR
Director
—
—
—
867,826
0.6904%
$21.72M
+0.9%
Topper David Joseph
Chief Financial Officer
—
—
—
182,774
0.1454%
$4.57M
+66.2%
Heron Patrick J
Director
—
—
—
59,661
0.0475%
$1.49M
+216.9%
Munshi Amit
Director
—
—
—
9,799
0.0078%
$245.23K
+390.0%
Peetz Christopher
Director
—
—
—
4,315
0.0034%
$107.99K
—

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Curran Terrie
27 Aug 2026
Director
Sold after exercise
27,052
$25.03
$677.10K
Curran Terrie
27 Aug 2026
Director
Sold after exercise
11,148
$25.03
$279.03K
Curran Terrie
20 Aug 2026
Director
Sold after exercise
1,072
$26.04
$27.91K
Welgus Howard G.
17 Aug 2026
Director
Sold after exercise
4,730
$26.18
$123.83K
Burnett Patrick
12 Aug 2026
See Remarks
Sold after exercise
6,700
$26.08
$174.77K
Burnett Patrick
11 Aug 2026
See Remarks
Sold after exercise
8,300
$26.52
$220.13K
Welgus Howard G.
15 Jul 2026
Director
Sold after exercise
4,730
$26.91
$127.28K
Welgus Howard G.
15 Jun 2026
Director
Sold after exercise
4,096
$24.41
$99.98K
Leonard Keith R
2 Mar 2026
Director
Sold after exercise
39,272
$25.39
$997.19K
Burnett Patrick
15 Dec 2025
See Remarks
Sold after exercise
11,500
$28.94
$332.85K
LIN SUE-JEAN
24 Nov 2025
Director
Sold after exercise
25,272
$30.78
$777.96K
Gilbert Halley E
20 Nov 2025
Director
Sold after exercise
16,532
$27.55
$455.44K
Krishnamohan Neha
13 Nov 2025
Director
Sold after exercise
1,232
$23.37
$28.79K
Krishnamohan Neha
13 Nov 2025
Director
Sold after exercise
39,272
$23.19
$910.70K
Burnett Patrick
6 Nov 2025
See Remarks
Sold after exercise
17,250
$24.18
$417.14K
Welgus Howard G.
1 Oct 2025
Director
Sold after exercise
462
$18.92
$8.74K
Welgus Howard G.
1 Oct 2025
Director
Sold after exercise
9,538
$18.92
$180.48K
Show all 82 transactions →

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 63
Sales straight out of an exercise 17
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 503,756
History held since 3 Feb 2020